Simon Mwaringa Dena

Simon Mwaringa Dena

Auto-generated profile, based on publicly available information

Simon Mwaringa Dena

Department of Medical Biosciences University of the Western Cape Bellville South Africa

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2025 in Journal of Diabetes
Verified
Journal Article
Open access
SDSimon Mwaringa Dena
Simon Mwaringa Dena
AAAdesola Oluwaseun Adeleye
Adesola Oluwaseun Adeleye
KMKutullo Mohlala
Kutullo Mohlala
BLBridget Cebisile Langa
Bridget Cebisile Langa
COChinyerum Opuwari
Chinyerum Opuwari
Diabetes mellitus (DM) significantly impairs male reproductive health, largely through hyperglycemia‐induced oxidative stress (OS). Elevated glucose activates detrimental metabolic pathways, notably the polyol pathway, which depletes antioxidant defenses and generates reactive oxygen species (ROS). This oxidative burden damages spermatozoa, leading to reduced motility, abnormal morphology, DNA fragmentation, and disrupted membrane integrity. OS also compromises the hypothalamic–pituitary–gonadal axis, lowering testosterone synthesis and impairing spermatogenesis. The formation of advanced glycation end products (AGEs) and chronic inflammation further exacerbate Leydig and Sertoli cell dysfunction, microvascular injury, and testicular apoptosis. Clinical evidence consistently links DM to deteriorated semen parameters, hormonal imbalances, and reduced natural conception rates, with poorer outcomes in assisted reproductive technologies. Obesity and metabolic syndrome, common comorbidities in DM, amplify oxidative stress and further impair fertility potential. While seminal plasma contains enzymatic and non‐enzymatic antioxidants, these defenses are often insufficient in diabetic men. Targeted interventions, including antioxidant therapy, lifestyle modifications, glycemic control, and management of comorbidities, offer promise in mitigating oxidative damage. This review synthesizes current evidence on the molecular, endocrine, and clinical consequences of DM‐related oxidative stress on male fertility, underscoring the need for integrated management strategies to preserve reproductive function in diabetic men.

11 November 2025 in Applied Research
Verified
Journal Article
Open access
AAAdesola Oluwaseun Adeleye
Adesola Oluwaseun Adeleye
SDSimon Mwaringa Dena
Simon Mwaringa Dena
OOOluwafemi Oguntibeju
Oluwafemi Oguntibeju
Salam TitinchiSalam Titinchi
Salam Titinchi
COChinyerum Opuwari
Chinyerum Opuwari
Non‐communicable diseases (NCDs), such as diabetes and cancer, are chronic medical conditions characterised by their persistent nature and gradual progression. They pose a significant challenge to global public health due to their widespread impact and increasing prevalence worldwide. According to the 2021 International Diabetes Federation atlas reports, 10.5% of adults worldwide currently live with diabetes, a figure projected to reach 783 million by 2045. Furthermore, cancer is one of the world's top causes of death, as reported by the WHO. Although synthetic drugs are widely used to manage these diseases, they often come with adverse side effects such as suppression of blood cell production, inflammation of mucous membranes, hair loss, and nausea. Curcumin, an active compound found in turmeric, has attracted interest due to its therapeutic potential in treating both diabetes and cancer, largely owing to its favourable safety profile, as evidenced by preclinical and clinical data. Nevertheless, poor bioavailability, rapid metabolism, and low stability in living systems have limited its clinical application. To address these limitations, recent research has focused on developing synthetic curcumin derivatives with improved pharmacokinetic properties. This review examines the antidiabetic and anticancer potentials of these derivatives, emphasising research data from both in vivo and in vitro studies. The paper also highlights how structural modifications significantly enhance their biological activity and provides a comparative mechanistic discussion linking diabetes and cancer at the molecular level, and translational gaps that define future research directions. This dual perspective in mechanisms distinguishes the present review from earlier works that examined curcumin's therapeutic potential in isolation within diabetes or cancer frameworks.